Truvada® Tablet, manufactured by Gilead Sciences, is a fixed-dose combination antiretroviral medication containing Tenofovir Disoproxil Fumarate 300 mg and Emtricitabine 200 mg per tablet. Specifically formulated for the treatment and prevention of HIV-1 infection, Truvada plays a pivotal role in modern HIV therapeutics and prophylaxis. In HIV treatment regimens, it is used alongside other antiretroviral agents to effectively suppress viral replication, diminish viral load, and elevate CD4 T-cell counts, thereby improving immune function. Importantly, Truvada is also approved and widely employed as Pre-Exposure Prophylaxis (PrEP) to significantly reduce the risk of HIV acquisition in individuals at high risk but currently HIV-negative. Its mechanism involves dual nucleoside/nucleotide reverse transcriptase inhibitors (NRTIs) that inhibit the viral reverse transcriptase enzyme, essential for HIV replication. Truvada offers a convenient once-daily oral dosing, enhancing patient adherence. Supplied in bottles of 30 film-coated tablets, it necessitates proper storage below 30°C and protection from moisture. Due to its clinical specificity, Truvada must be used under strict medical supervision with routine monitoring of kidney function and bone health. It is not a cure for HIV/AIDS but a critical component in long-term disease management strategies.
Key Features
| Features | Description |
|---|---|
| Active Ingredients | Tenofovir Disoproxil Fumarate 300 mg and Emtricitabine 200 mg per tablet |
| Therapeutic Use | Treatment of HIV-1 infection in combination therapy and HIV prevention via PrEP |
| Mechanism of Action | Inhibits reverse transcriptase enzyme to block HIV replication |
| Dosage | One tablet orally once daily, with or without food |
| Packaging | Bottles containing 30 film-coated tablets |
| Administration Route | Oral |
| Manufacturer | Gilead Sciences |
| Storage Conditions | Store below 30°C, keep tightly closed, protect from moisture |
| Key Benefits | Proven efficacy in HIV suppression; widely recommended for PrEP and therapy |
| Safety Monitoring | Regular kidney function and bone health monitoring recommended |
| Attributes | Description |
|---|---|
| Composition (per tablet) | Tenofovir Disoproxil Fumarate 300 mg, Emtricitabine 200 mg |
| Therapeutic Category | Antiretroviral (HIV Medicine) |
| Indications | HIV-1 treatment (in combination), HIV prevention (PrEP) |
| Pharmacological Class | Nucleoside/Nucleotide Reverse Transcriptase Inhibitors (NRTIs) |
| Formulation | Film-coated tablets |
| Dose Frequency | Once daily |
| Use Instructions | Administer orally, may be taken with or without food |
| Precautions | Not for monotherapy; requires medical supervision; monitor renal & bone health |
| Storage | Below 30°C, avoid moisture, keep out of children's reach |
| Shelf Life | As per packaging (consult manufacturer) |
| Country of Manufacture | Information available from Gilead Sciences |
*Disclaimer: The above description has been AI-generated and has not been audited or verified for accuracy. It is recommended to verify product details independently before making any purchasing decisions.
No, Truvada must not be used as monotherapy for HIV treatment. It is always prescribed as part of a combination antiretroviral regimen.
Patients on Truvada should undergo regular kidney function tests and bone mineral density assessments to monitor potential adverse effects.
Yes, confirming the individual's HIV-negative status before starting PrEP with Truvada is imperative to avoid resistance development.
Truvada can be taken with or without food, providing flexibility to the patient’s daily routine.
Store Truvada tablets below 30°C in a tightly closed container and protect them from moisture to preserve stability.
Country Of Origin: India
Product Name: Truvada® Tablet
Manufacturer: Gilead Sciences
Composition (per tablet):
• Tenofovir Disoproxil Fumarate (TDF) 300 mg
• Emtricitabine (FTC) 200 mg
Therapeutic Category:
Antiretroviral (HIV Medicine)
Product Description:
Truvada® is a fixed-dose antiretroviral combination containing Tenofovir Disoproxil Fumarate and Emtricitabine. It is widely used in the treatment and prevention of HIV-1 infection.
Indications:
Mechanism of Action:
Dosage & Administration:
Key Benefits:
Packaging: Bottles containing 30 film-coated tablets.
Storage:
Important Notes:
Inclusive of all taxes
You Save: 0
Rajkot , India
Manufacturer, Professional Services, Distributor, Exporter, Importer, Wholesaler, Startup
GST- 24gqfpm5460r1z4
